Regen Biopharma Inc Receivables Turnover Ratio (RGBP), from the third quarter 2026 to the third quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Regen Biopharma Inc   (RGBP)
 

Regen Biopharma Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Regen Biopharma Inc 's ability to collect accounts receivable sequentially worsen to 0.99, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Regen Biopharma Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 369 days, from 326 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 525 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3414, from overall ranking in the second quarter 2026 at 3887.

What is Receivable Turnover Ratio?
What is Regen Biopharma Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

RGBP Receivables Turnover Ratio (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Receivable Change 62.1 % 73.47 % 115.94 % 115.94 % 163.82 %
Y / Y Revenue Change 0 % 0 % 0 % -48.02 % 0 %
Receivable Turnover Ratio (TTM) 0.99 1.12 1.28 1.51 2.26
RGBP's Total Ranking # 3414 # 3887 # 3504 # 3462 # 3391
Accounts Receivable average collection period days 369 327 284 242 162
Seq. Receivable Change 10.56 % 26.77 % 0 % 15.65 % 18.32 %
Seq. Revenue Change 0 % 0 % -0.51 % 0.51 % 0 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 175
Healthcare Sector # 526
Overall Market # 3414

Receivable Turnover Ratio Statistics
High Average Low
5.76 1.85 0.46
(Jun 30 2024)   (Dec 31 2022)





RGBP Company Profile • Back to RGBP Efficiency Comparisons • Compare RGBP Receivables Turnover Ratio to its Competitors

Financial Statements
Regen Biopharma Inc 's Accounts Receivable $ 0 Millions Visit RGBP's Balance sheet
Regen Biopharma Inc 's Sales TTM $ 0 Millions Visit RGBP's Income Statement
Sources of RGBP's Revenues Visit RGBP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
RGBP's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
RGBP's Growth Rates RGBP's Roa RGBP's Inventory Turnover Ratio RGBP's Dividend Comparisons
RGBP's Profitability Ratios RGBP's Roi RGBP's Asset Turnover Ratio RGBP's Dividend Growth
RGBP's Valuation Ratios RGBP's Roe RGBP's Financial Strength Ratios RGBP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Co diagnostics Inc   2.14 $ 0.721  Millions$ 0.337  Millions
Profound Medical Corp   2.14 $ 19.086  Millions$ 8.924  Millions
60 Degrees Pharmaceuticals Inc   2.13 $ 1.111  Millions$ 0.522  Millions
Cardio Diagnostics Holdings Inc   2.10 $ 0.014  Millions$ 0.007  Millions
Scilex Holding Company  1.93 $ 31.608  Millions$ 16.396  Millions
Heron Therapeutics Inc   1.76 $ 151.507  Millions$ 85.975  Millions
Bio Green Med Solution Inc   1.75 $ 1.861  Millions$ 1.061  Millions
EBR Systems, Inc.  1.74 $ 6.446  Millions$ 3.714  Millions
Cytomx Therapeutics Inc   1.69 $ 18.302  Millions$ 10.821  Millions
Biocorrx Inc   1.67 $ 0.787  Millions$ 0.471  Millions
Prophase Labs Inc   1.59 $ 3.150  Millions$ 1.977  Millions
Amarin Corp Plcuk  1.49 $ 186.480  Millions$ 125.559  Millions
Skinvisible Inc   1.45 $ 0.020  Millions$ 0.014  Millions
Lightwave Logic Inc   1.40 $ 0.250  Millions$ 0.178  Millions
Roivant Sciences Ltd   1.39 $ 7.532  Millions$ 5.400  Millions
Clene Inc   1.15 $ 0.197  Millions$ 0.171  Millions
Instil Bio Inc   1.15 $ 8.968  Millions$ 7.822  Millions
Scienture Holdings Inc   1.15 $ 0.821  Millions$ 0.717  Millions
Regen Biopharma Inc   0.99 $ 0.237  Millions$ 0.239  Millions
Prokidney Corp   0.75 $ 0.818  Millions$ 1.088  Millions
Cardiff Lexington Corporation  0.46 $ 10.213  Millions$ 22.347  Millions

Date modified: 2026-08-18T07:46:10+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.